Evidence map›Paper›PMID 31323754›Full record

ArticleMolecules (Basel, Switzerland)2019

Extraction, Chemical Composition, and Anticancer Potential of

Katerina Spyridopoulou, Eleni Fitsiou, Eleni Bouloukosta, Angeliki Tiptiri-Kourpeti, Manolis Vamvakias, Antigoni Oreopoulou, Eleni Papavassilopoulou, Aglaia Pappa, Katerina Chlichlia

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Evaluating the Chemical Composition and Antitumor Activity ofInternational journal of molecular sciences · 2025
    Article
  4. Review
  5. Frontiers in pharmacology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Molecules (Basel, Switzerland) · 2022
    Article
  14. Insight into Analysis of Essential Oil fromPlants (Basel, Switzerland) · 2021
    Article
  15. Antitumor Potential ofAntioxidants (Basel, Switzerland) · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Katerina SpyridopoulouDepartment of Molecular Biology and Genetics, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.ORCID 0000-0003-4905-9567
Eleni FitsiouDepartment of Molecular Biology and Genetics, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Eleni BouloukostaDepartment of Molecular Biology and Genetics, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Angeliki Tiptiri-KourpetiDepartment of Molecular Biology and Genetics, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Manolis VamvakiasVIORYL S.A., Chemical & Agricultural Industry, Research S.A., 19014 Afidnes, Greece.
Antigoni OreopoulouVIORYL S.A., Chemical & Agricultural Industry, Research S.A., 19014 Afidnes, Greece.
Eleni PapavassilopoulouVIORYL S.A., Chemical & Agricultural Industry, Research S.A., 19014 Afidnes, Greece.
Aglaia PappaDepartment of Molecular Biology and Genetics, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece.
Katerina ChlichliaDepartment of Molecular Biology and Genetics, Democritus University of Thrace, University Campus-Dragana, 68100 Alexandroupolis, Greece. achlichl@mbg.duth.gr.ORCID 0000-0003-4952-0675
Democritus University of Thrace · GRVioryl (Greece) · GR

Funding

European Regional Development Fund 12CHN_409National Roadmap for Research Infrastructures, General Secretariat for Research and Technology OPENSCREEN-GR
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic Agents, PhytogenicCell Line, TumorCell MovementCell ProliferationChemical FractionationDisease Models, AnimalDose-Response Relationship, DrugFemaleGas Chromatography-Mass SpectrometryHumansMiceOils, VolatileOriganumPhytochemicalsPlant ExtractsAntineoplastic Agents, PhytogenicOils, VolatilePhytochemicalsPlant Extractsantitumorcolon canceressential oiloral administrationOriganum onites

Identifiers

PMID31323754
PMCPMC6680447
OpenAlexW2959616682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.